Abstract
Guillain–Barré syndrome is a rare complication in the setting of hematopoietic stem cell transplantation. We report three children with T cell lymphoma/leukemia in whom this syndrome developed soon after they received unrelated donor transplants. The rapid onset of symptoms raises the concern that the bone marrow transplant conditioning regimen (ie, total body irradiation, cyclophosphamide and cytosine arabinoside) might have precipitated the clinical syndrome of ascending polyneuropathy. Although central nervous system toxicity has been well described with high-dose cytosine arabinoside therapy, peripheral neuropathy of the Guillain–Barré type has been reported only infrequently. We review possible factors contributing to the development of this syndrome in these three patients.
Bone Marrow Transplantation (2002) 29, 515–517. doi:10.1038/sj.bmt.1703412
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johnson NT, Crawford SW, Sargur M . Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation Bone Marrow Transplant 1987 2: 203 207
Patchell RA, White CL III, Clark AW et al. Neurologic complications of bone marrow transplantation Neurology 1985 35: 300 306
Graus F, Rogers LR, Posner JB . Cerebrovascular complications in patients with cancer Medicine (Baltimore) 1985 64: 16 35
Hahn AF . Guillain–Barré syndrome Lancet 1998 352: 635 641
Hongeng S, Krance RA, Bowman LC et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia Lancet 1997 350: 767 771
Sater RA, Rostami A . Treatment of Guillain-Barré syndrome with intravenous immunoglobulin Neurology 1998 51 (Suppl. 5): S9 S15
Mudad R, Hussein A, Peters WP . Guillain–Barré syndrome following autologous bone marrow transplantation Am J Clin Oncol 1995 18: 167 169
Myers SE, Williams SF . Guillain–Barré syndrome after autologous bone marrow transplantation for breast cancer: report of two cases Bone Marrow Transplant 1994 13: 341 344
Perry A, Mehta J, Iveson T et al. Guillain–Barré syndrome after bone marrow transplantation Bone Marrow Transplant 1994 14: 165 167
Wen PY, Alyea EP, Simon D et al. Guillain–Barré syndrome following allogeneic bone marrow transplantation Neurology 1997 49: 1711 1714
Lopez JA, Agarwal RP . Acute cerebellar toxicity after high-dose cytarabine associated with CNS accumulation of its metabolite, uracil arabinoside Cancer Treat Rep 1984 68: 1309 1310
Duffy TP . How much is too much high-dose cytosine arabinoside? J Clin Oncol 1985 3: 601 603
Nand S, Messmore HL Jr, Patel R et al. Neurotoxicity associated with systemic high-dose cytosine arabinoside J Clin Oncol 1986 4: 571 575
Aguayo A, Cortes JE, Kantarjian HM et al. Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelo-genous leukemia in T-cell blastic phase: a case report and review of the literature Cancer 1999 85: 58 64
Kurtzberg J, Keating MJ, Plunkett W et al. Compound 506 (2-amino-6-methoxypurine arabinoside) is active against resistant T-cell malignancies: preliminary results of an ongoing phase I trial (abstract) J Clin Oncol 1996 14: 1750
Dunton SF, Nitschke R, Spruce WE et al. Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group study Cancer 1986 57: 1083 1088
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodriguez, V., Kuehnle, I., Heslop, H. et al. Guillain–Barré syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 29, 515–517 (2002). https://doi.org/10.1038/sj.bmt.1703412
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703412
Keywords
This article is cited by
-
Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation
Bone Marrow Transplantation (2018)
-
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease
Journal of Neuro-Oncology (2012)
-
Brachial plexopathy following high-dose melphalan and autologous peripheral blood stem cell transplantation
Bone Marrow Transplantation (2010)
-
Rituximab-responsive Guillain–Barré syndrome following allogeneic hematopoietic SCT
Bone Marrow Transplantation (2008)
-
Immune-mediated motor polyneuropathy after hematopoietic stem cell transplantation
Bone Marrow Transplantation (2007)